Pharmafile Logo
Pharmafocus logo
Advanced Search

FDA greenlights Pfizer biosimilar version of Genentech’s Avastin

July 1, 2019
Sales and Marketing Cancer, Genentech, Pfizer, pharma, pncology

Pfizer is celebrating the approval by the FDA of Zirabev, its biosimilar version of Genentech’s Avastin (bevacizumab), which is now …

News

Pfizer’s Revatio flops in Phase 3 trial

July 1, 2019
Sales and Marketing

American multinational Pfizer has said that Revatio (Sildenafil Citrate) in combination with nitric oxide, has failed to meet its primary …

News
medical-supplies-paper-bag

Medicines recalled after FMD alert

July 1, 2019
Sales and Marketing FMD, MHRA, labels, pharma, recall, supply chain

The MHRA has warned patients that batches of drugs for Parkinson’s, epilepsy and blood clots have been taken out of …

News
julyaugust_2019_cover

Read the July/August edition of Pharmafocus online now!

June 28, 2019
Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing NHS, Orkambi, Trump, UK, brexit, generics, manufacturing compliance, pharma

The latest monthly edition of Pharmafocus, the July/August issue, is available to read for free online now!The UK remains split …

News
4420456374_64a3d7e6aa

Top Ten most popular articles on Pharmafile.com this week

June 28, 2019
Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing AbbVie, Allergan, Bristol-Myers Squibb, China, GSK, Novartis, Takeda, brexit

This week was diverse as always in terms of news coming out of the pharma industry, but the biggest news …

News
shutterstock_114045100

ImmunoGen to axe 220 positions as part of new restructuring strategy

June 28, 2019
Manufacturing and Production, Medical Communications Immunogen, pharma

ImmunoGen has announced that, following an in-depth operational review to “extend the company’s cash runway”, it will be implemented a …

News
janssen_latest_logo_on_sign

Janssen’s Darzalex combo approved by FDA in transplant-ineligible multiple myeloma patients

June 28, 2019
Medical Communications, Sales and Marketing Janssen, darzalex, mutiple myeloma, pharma

Janssen’s Darzalex (daratumumab) has secured FDA approval in combination with lenalidomide and dexamethasone for the treatment of newly diagnosed multiple …

News
scott_gottlieb_getty_images

Former FDA Commissioner Scott Gottlieb elected to Pfizer’s Board of Directors

June 28, 2019
Medical Communications FDA, Pfizer, Scott Gottlieb, pharma

Dr Scott Gottlieb, who stepped down from his role as the 23rd Commissioner of the FDA earlier this year, has …

News
shutterstock_158366573

Healthcare communications: Time to think differently with patient centricity

June 27, 2019
Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing Spink, patient centricity, pharma

Patient centricity, derived from the NHS-driven thinking “no decision about me, without me”, has been adopted by pharma to understand …

Feature
512px-hpv_causing_cervical_cancer

Major review points to success of HPV vaccine, cervical cancer could be eradicated in developed nations

June 27, 2019
Research and Development Cancer, HPV, UK, cervical cancer, human papilloma virus, pharma, vaccines

A major new review published in The Lancet has supported the effectiveness of the human papilloma virus (HPV) vaccine in …

News
dw-anzcxqaqavhl

FDA approves Dupixent for chronic rhinosinusitis with nasal polyposis

June 27, 2019
Sales and Marketing Dupixent, FDA, Sanofi, US, pharma, rhinosinusitis

Regeneron Pharmaceuticals and Sanofi have revealed that their dual IL-4 and IL-13 inhibitor Dupixent (dupilumab) has secured FDA approval in …

News
opioid_therapy_credit_-_us_air_force_valerie_monroy

Titan Therapeutics’ opioid dependence implant Sixmo approved in Europe

June 27, 2019
Sales and Marketing Molteni, Sixmo, Titan Therapeutics, pharma

The European Commission has awarded marketing approval to Sixmo, a subdermal buprenorphine implant from Titan Therapeutics and Molteni, in all …

News
astrazeneca-sign

AstraZeneca’s Imfinzi meets endpoint at Phase 3 interim analysis in extensive-stage small cell lung cancer

June 27, 2019
Research and Development AstraZeneca, Imfinzi, pharma

AstraZeneca has lifted the curtain on new Phase 3 data for Imfinzi (durvalumab) in the first-line treatment of extensive-stage small …

News
takeda_deerfield_hq

Takeda plans to vacate all 1,000 staff from US HQ by the year’s end

June 26, 2019
Manufacturing and Production, Medical Communications, Sales and Marketing Shire, Takeda, US, pharma

Takeda has announced its plans to vacate all staff from its US headquarters in Deerfield, Illinois, by the end of …

News
antibiotic_sensitvity_and_resistance

Rare Group A strep outbreak kills 12 and infects 20 in Essex

June 26, 2019
Medical Communications, Research and Development England, NHS, UK, outbreak, pharma

An outbreak of the rare contagious bacteria Group A streptococcal (iGAS) infection in Essex, UK, has resulted in 32 cases …

News
novartis_side_building

Novartis provides promising update on Cosentyx in plaque psoriasis

June 26, 2019
Research and Development Cosentyx, Novartis, pharma, psoriasis

Novartis has revealed brief new data on its IL-17A antibody Cosentyx (secukinumab) in the treatment off plaque psoriasis, showing that …

News
acer_therapeutics

Acer’s shares drop 80% as FDA rejects drug for vascular Ehlers-Danlos syndrome

June 26, 2019
Research and Development, Sales and Marketing Acer Therapeutics, Edsivo, pharma

Acer Therapeutics has seen its share value plunge by 80% after it emerged that the FDA had turned down its …

News
shutterstock_273326141

AbbVie poised to acquire Allergan for $63 billion

June 26, 2019
Research and Development, Sales and Marketing AbbVie, Allergan, acqusition, pharma

The industry has been rocked with the announcement of another pharmaceutical mega-merger, as it emerged that AbbVie had sealed an …

News

China urges firms to make generic versions of 34 drugs

June 25, 2019
Research and Development China, NHC, generic drugs, generics, patents, pharma

China’s National Health Commission (NHC) has urged generic drugmakers to pick up the production of 34 drugs that are not …

News
w36

FREE WEBINAR: Virtually engaged or engaged virtually?

June 25, 2019
Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing Webinar, Within3, pharma

In just over a week, on Wednesday 4 July, Pharmafocus will be collaborating with Healthcare Engagement Solutions firm Within3 to …

News
The Gateway to Local Adoption Series

Latest content

Complement Therapeutics’ geographic atrophy treatment receives FDA Fast Track designation

January 22, 2026

PSI appoints David Allen as Country Manager for Canada

January 22, 2026

Qureight appoints Steven Bishop as Chief Medical Officer

January 21, 2026

Pierre Fabre Laboratories and Iktos announce oncology collaboration

January 21, 2026

Qureight appoints Rebecca Simmons as Chief Operating Officer

January 20, 2026